NICE explores extending use of real world data to inform guidance
A consultation has begun on NICE’s Statement of Intent.
Read Moreby Anna Smith | Jun 27, 2019 | News | 0
A consultation has begun on NICE’s Statement of Intent.
Read Moreby Anna Smith | May 22, 2019 | News | 0
The company will provide Sanofi with information going back to 1994.
Read Moreby Anna Smith | Apr 11, 2019 | News | 0
The companies have entered into a precision oncology collaboration.
Read Moreby Anna Smith | Mar 29, 2019 | News | 0
The partnership will give the American pharma giant access to Concerto’s eurekaHealth AI insights platform.
Read Moreby Selina McKee | Dec 14, 2017 | News | 0
A pooled analysis of real-world data from over 2,000 patients with epilepsy has shown that Eisai and Bial’s Zebinix is safe and effective when switching from previous treatment with carbamazepine or oxcarbazepine.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
